(S)-1-(4-fluoro-2-methyl-2H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1H-imidazol-2(3H)-one
CAS No.2212022-56-3
Hechi Vice Mayor Chen Zhijie toured Tianming Pharmaceutical’s facilities, praising its R&D strength and the “Jinan R&D + Hechi production” model.
This non-peptide GLP-1 receptor agonist, now in late-stage clinical trials, is redefining possibilities for diabetes and obesity treatment. Let’s unpack what makes it distinctive from both lab bench and manufacturing perspectives.
Comprehensive guide to 2-methylpentanoic acid’s pharmaceutical synthesis roles, industrial applications (lubricants/flavors), production optimization, GMP quality parameters, and global regulatory compliance requirements.
Tianming Pharmaceutical Group commercializes high-purity (R)-3-Chloro-1-phenyl-1-propanol via green synthesis tech, accelerating sustainable SSRI production while slashing costs and environmental impact.
Abiraterone, a prostate cancer treatment, inhibits CYP17 enzymes to disrupt androgen synthesis. It provides therapeutic benefits but may cause fatigue, hypertension, and hepatotoxicity.
Pharma experts: Unlock breakthrough CNS treatments with our dapoxetine HCl. Rigorous quality control, crystal engineering expertise, and FDA/EMA compliance ensure your success.